Search for: "BAYER MANUFACTURING" Results 641 - 660 of 982
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Feb 2012, 2:37 pm
Overview of Xarelto (rivaroxaban) Xarelto (rivaroxaban) is an anti-coagulant (blood thinner) manufactured by Bayer, marketed by Janssen Pharmaceutica in the United States, that targets blood clotting Factor Xa, interrupting the blood clotting cascade. [read post]
14 Oct 2015, 10:26 am by Joe Consumer
Manufacturer Bayer estimates 750,000 women have received the device since 2002. [read post]
11 Jan 2011, 11:07 pm by Kelly
Supreme Court to take on patent settlement agreements: Louisiana Wholesale Drug Co et al v Bayer et al (FDA Law Blog) US: BIO joins 170 business, research institutions and organisations to urge caution in Microsoft v i4i case (PatentlyBIOtech) US: Galderma wins important victory in fight against Leo’s psoriasis patent covering vitamin D, corticosteroid composition for ‘dermal use’ (Reexamination Alert) US: Déjà vu! [read post]
3 Aug 2020, 7:17 am by Pete Strom
However, numerous personal injury lawsuits have been filed recently against the manufacturer, Bayer, because the device damaged women’s internal organs, or the device simply migrated to a place where it was no longer effective in preventing pregnancy. [read post]
15 Jul 2011, 6:41 am
There are about 1,000 Yaz, Yasmin and Ocella product liability lawsuits pending in New Jersey state courts involving claims that women suffered serious or deadly injuries as a result of side effects of Yaz, Yasmin or Ocella birth control, containing the fourth-generation progestin drospirenone which are all manufactured by Bayer. [read post]
6 Oct 2014, 4:41 pm by Dr. Shezad Malik
Xarelto Increasd Adverse Reports As the usage of Xarelto increases in the United States, many Xarelto uncontrollable bleeding lawsuits are being filed against Bayer AG, and Johnson and Johnson, the manufacturers and distributors of Xarelto. [read post]
11 Aug 2012, 5:22 am by Ed Wallis
Manufactured by Bayer Healthcare Pharmaceuticals, Inc., Mirena is an IUD device [intrauterine device] that must be inserted by a trained health care provider and is intended to provide contraceptive protection for up to five years. [read post]
29 Sep 2009, 7:21 am
The Dalkon Shield is considered a watershed case because it caused both government agencies and manufacturers of pharmaceuticals and medical devices to seriously overhaul the way that they tested and marketed their products. [read post]
29 Sep 2009, 7:21 am
The Dalkon Shield is considered a watershed case because it caused both government agencies and manufacturers of pharmaceuticals and medical devices to seriously overhaul the way that they tested and marketed their products. [read post]
23 Jul 2012, 6:11 pm
Bayer Corp., the U.S. unit of Germany's Bayer AG, BAYN 0.00% finds itself in just such a morass. [read post]
20 May 2010, 7:30 am by FDABlog HPM
Strauss of the Superior Court of California, County of San Diego, in which he granted motions for summary judgment ruling that Bayer AG and several generic drug manufacturers did not violate the Cartwright Act – California’s antitrust law and an analogue to Section 1 of the federal Sherman Act – when Bayer settled patent infringement litigation with respect to generic versions of its antibiotic drug CIPRO (cirprofloxacin HCl). [read post]
1 May 2009, 9:00 am
  Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement suit over Barr’s ANDA to manufacture generic Alimta (Patent Docs) Arthrotech (Diclofenac/Misoprostol) – US: Pfizer files patent infringement suit against Teva over generic Arthrotech ANDA (Patent Docs) Enablex (Darifenacin hydrobromide) – US: Watson files ANDA to market generic Enablex prior to expiration of Novartis’ patent (GenericsWeb) Flanax (Naproxen)… [read post]
7 Jan 2010, 4:07 am
Following Denial of Class Action Treatment, Federal Court did not Abuse Discretion in Granting Defense Motion to Enjoin State Court from Ruling on Class Action Certification Motion of Identical Claims brought by Different Plaintiffs Eighth Circuit Court Holds Plaintiff George McCollins filed a putative class action against Bayer and other defendants, “who manufactured and produced Baycol, a prescription cholesterol lowering medication,” seeking damages for breach… [read post]
18 Jul 2019, 11:24 pm by Florian Mueller
The key doctrine there was that the scope of protection of a manufacturing patent potentially extends to the output if the substance so produced is an integral part of the patented process. [read post]
1 May 2014, 4:59 am
  At most, Teva could have sought assistance from the FDA in convincing Bayer to adopt a stronger label for Yaz so it could do the same with regard to Gianvi. [read post]